Hadasit profiles breadth of its innovative technology pipeline
This article was originally published in Clinica
Executive Summary
There are few medtech sectors in which technology transfer company Hadasit does not have a stake. With a range of novel medical inventions under its belt, the Israeli firm believes it has a strong IP position. Clinica's Claire Thomas caught up with marketing VP Stewart Bernstein to ask about the company's plans to capitalise on its diverse product pipeline
You may also be interested in...
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.